Conference Highlights. 25TH ANNUAL MEETING OF THE SOCIETY OF UROLOGIC ONCOLOGY.

Detalles Bibliográficos
Publicado en:Urology Times Vol. 53; no. 2; pp. 12 - 15
Autores principales: CLARKE, HANNAH, SAYLOR, BENJAMIN P.
Formato: pictorial Journal Article
Publicado: MJH Life Sciences Feb2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=183603122&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 183603122
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00939722
        URO
      jtl: Urology Times
      issn: 00939722
      maglogo: N
    pubinfo:
      dt: Feb2025
      vid: 53
      iid: 2
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        183603122
        183603122
        183603122
        183603122
      ppf: 12
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Conference Highlights. 25TH ANNUAL MEETING OF THE SOCIETY OF UROLOGIC ONCOLOGY.
      aug:
        au:
          CLARKE, HANNAH
          SAYLOR, BENJAMIN P.
      sug:
        subj:
          Congresses and Conferences Texas
          Oncology Organizations
          Urology Organizations
          Texas
          Non-Muscle Invasive Bladder Neoplasms Drug Therapy
          Drug Tolerance
          Oncolytic Virotherapy
          Prostatic Neoplasms, Castration-Resistant Prognosis
          Neoplasm Metastasis
          Enzyme Inhibitors Therapeutic Use
          Progression-Free Survival
          Overall Survival
          Carcinoma, Renal Cell Drug Therapy
          Antineoplastic Agents Therapeutic Use
      pubtype: Academic Journal
      doctype:
        pictorial
        Journal Article
      ougenre: Unknown
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N